mFOLFIRINOX Treatment Regimen Clinical Trials
4 recruitingDrug
Phase 23Phase 12
Showing 1–4 of 4 trials
Recruiting
Phase 1
To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors
Pancreatic Ductal Adenocarcinoma (PDAC)Hepatocellular Carcinoma (HCC)Gastric Cancer (GC)+1 more
Shenzhen Xinhe Biomedical48 enrolled2 locationsNCT07594964
Recruiting
Phase 2
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples
Pancreatic Cancer
Medical College of Wisconsin84 enrolled2 locationsNCT04683315
Recruiting
Phase 1Phase 2
A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab
Pancreatic Cancer MetastaticAnal Cancer MetastaticSquamous Cell Carcinoma of the Anus Stage Unspecified+1 more
Oncolytics Biotech122 enrolled15 locationsNCT07280377
Recruiting
Phase 2
DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer
Pancreas Neoplasms
Hopital Foch35 enrolled5 locationsNCT06757244